LEMBOREXANT

UNII:	0K5743G68X
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₂H₂₀F₂N₄O₂
Preferred Substance Name:	LEMBOREXANT
InChIKey:	MUGXRYIUWFITCP-PGRDOPGGSA-N
GSRS Full Record:	0K5743G68X i

1369764-02-2
(1R,2S)-2-((2,4-DIMETHYLPYRIMIDIN-5-YL)OXYMETHYL)-2-(3-FLUOROPHENYL)-N-(5-FLUOROPYRIDIN-2-YL)CYCLOPROPANE-1-CARBOXAMIDE
(1R,2S)-2-{[(2,4-Dimethylpyrimidin-5-yl)oxy]methyl}-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide
CYCLOPROPANECARBOXAMIDE, 2-(((2,4-DIMETHYL-5-PYRIMIDINYL)OXY)METHYL)-2-(3-FLUOROPHENYL)-N-(5-FLUORO-2-PYRIDINYL)-, (1R,2S)-
DAYVIGO
DEA NO. 2245
E-2006
E2006
LEMBOREXANT [JAN]
LEMBOREXANT [MI]
LEMBOREXANT [ORANGE BOOK]
LEMBOREXANT [USAN]
Lemborexant [WHO-DD]
cis-(1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)cyclopropane-1-carboxamide
cis-(1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)cyclopropane-1-carboxamide
lemborexant [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LEMBOREXANT

Synonyms and Mappings

Resources